CHOLINERGIC MATURATION AND SCH-23390-INDUCED CATALEPSY IN THE MALE-RAT PUP

被引：24

作者：

FITZGERALD, LW

HANNIGAN, JH

机构：

[1] SUNY ALBANY,CTR BEHAV TERATOL,SS-112,1400 WASHINGTON AVE,ALBANY,NY 12222

[2] SUNY ALBANY,DEPT PSYCHOL,ALBANY,NY 12222

来源：

DEVELOPMENTAL BRAIN RESEARCH | 1989年 / 47卷 / 01期

关键词：

D O I：

10.1016/0165-3806(89)90118-1

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：147 / 150

页数：4

共 14 条

[1] ARBILLA S, 1987, NEUROTRANSMITTER INT, P111
[2] RELATIVE DOPAMINE D1 AND D2 RECEPTOR AFFINITY AND EFFICACY DETERMINE WHETHER DOPAMINE AGONISTS INDUCE HYPERACTIVITY OR ORAL STEREOTYPY IN RATS
ARNT, J
BOGESO, KP
HYTTEL, J
MEIER, E
[J]. PHARMACOLOGY & TOXICOLOGY, 1988, 62 (03): : 121 - 130
[3] POSTNATAL-DEVELOPMENT OF A CHOLINERGIC INFLUENCE ON NEUROLEPTIC-INDUCED CATALEPSY
BURT, DK
HUNGERFORD, SM
CROWNER, ML
BAEZ, LA
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 16 (04) : 533 - 540
[4] SCOPOLAMINE MODULATES APOMORPHINE-INDUCED BEHAVIOR IN RATS TREATED WITH HALOPERIDOL OR SCH-23390
BUTKERAIT, P
FRIEDMAN, E
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) : 269 - 272
[5] ONTOGENESIS OF DOPAMINERGIC-CHOLINERGIC INTERACTIONS IN RAT STRIATUM - NEUROCHEMICAL STUDY
COYLE, JT
CAMPOCHIARO, P
[J]. JOURNAL OF NEUROCHEMISTRY, 1976, 27 (03) : 673 - 678
[6] SPECIFIC-INHIBITION OF DOPAMINE-D-1-MEDIATED CYCLIC-AMP FORMATION BY DOPAMINE-D-2, MUSCARINIC CHOLINERGIC, AND OPIATE RECEPTOR STIMULATION IN RAT STRIATAL SLICES
KELLY, E
NAHORSKI, SR
[J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (05) : 1512 - 1516
[7] D-1 AND D-2 RECEPTOR BLOCKADE HAVE ADDITIVE CATALEPTIC EFFECTS IN MICE, BUT RECEPTOR EFFECTS MAY INTERACT IN OPPOSITE WAYS
KLEMM, WR
BLOCK, H
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) : 223 - 229
[8] HALOPERIDOL DIFFERENTIALLY POTENTIATES TONIC IMMOBILITY, THE DORSAL IMMOBILITY RESPONSE, AND CATALEPSY IN THE DEVELOPING RAT
MEYER, ME
SMITH, RL
VANHARTESVELDT, C
[J]. DEVELOPMENTAL PSYCHOBIOLOGY, 1984, 17 (04) : 383 - 389
[9] MURRIN LC, 1986, BIOCHEM PHARMACOL, V35, P1159, DOI 10.1016/0006-2952(86)90154-1
[10] SCATTON B, 1986, EUR J PHARMACOL, V129, P359

← 1 2 →